Immunome, Inc. (IMNM)
19.32
-0.98
(-4.83%)
USD |
NASDAQ |
Dec 11, 15:19
Immunome Market Cap: 1.772B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Precision BioSciences, Inc. | 65.09M |
| CEL-SCI Corp. | 19.63M |
| AIM ImmunoTech, Inc. | 1.116M |
| IGC Pharma, Inc. | 30.33M |
| NovaBay Pharmaceuticals, Inc. | 370.47M |
Market Cap Related Metrics
| PS Ratio | 158.23 |
| Price to Book Value | 6.714 |
| Price | 19.32 |
| Earnings Yield | -15.30% |